Looking to Partner with the World CNS Series?
Following a year of significant pharma acquisitions, approvals of transformative drugs the first of their kind, and a surge of financial backing to bolster innovation in new targets and preclinical pipelines, 2027 is set to continue this momentum, with more companies prioritizing neuroscience drug development than ever before.
If you have relevant capabilities in this space and would like to align your brand with the CNS community, contact us to promote your capabilities through a bespoke commercial package.
Having trouble downloading the brochure? Let us know and we’ll email it to you instead.
Download Your Copy of the Sponsorship Prospectus
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Angus Booth
Partnerships Director
Explore the Agenda
Discover exactly how industry leaders are facing the most important development challenges – from targeted muscle delivery, patient pool selection and preclinical model translatability.
Partner With Us
Position your solutions in front of decision-makers actively looking to optimize their muscular disorder drug development, to become a trusted partner and build lasting relationships to support long term success.
Join Biopharma Leaders
Connect with the Muscular Disorder community and be part of the hottest conversations with like-minded attendees and gain access to insights only shared in our innovative face-to face networking sessions.